HUL is the safe FMCG bet that has gone nowhere. The question is whether FY27 finally moves it (NSE: HINDUNILVR)
Read More Pharma Industry News Exonics Therapeutics receives $5m seed funding to advance Duchenne Muscular Dystrophy therapy Exonics Therapeutics, a biotechnology firm based in Boston, Massachusetts, has secured $5 million in seed funding from CureDuchenne… bypharmanewsdailyFebruary 28, 2017